article thumbnail

Realm of Caring Appoints Research Director to Oversee Groundbreaking Cannabis Data Registry and Medical Studies

Cannabis Law Report

plan to conduct a controlled clinical trial to further understand the effects of CBD in epilepsy treatment. The 501(c)(3) high-impact independent public charitable organization has served tens of thousands of families and healthcare professionals since its inception in 2013. About Realm of Caring. Lindsey Clarke.

Data 81
article thumbnail

Canada Opens Access for Psilocybin and MDMA Therapy

Cannabis Law Report

Each request is decided on a patient-by-patient basis and approval is usually only given to drugs with successful phase II or phase II clinical trials. In 2013, section C and J of Canada’s FDR statute were amended so that “restricted drugs” were inaccessible through SAP. Subsection 56(1) Exemption.

Therapy 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Press Release: Algernon Pharmaceuticals Completes Manufacturing of Psychedelic Drug DMT Appoints UK Stroke Experts for Phase 2

Cannabis Law Report

(the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPD) a clinical stage pharmaceutical development company is pleased to announce that it has completed the manufacturing of its clinical grade supply (“cGMP”) of AP-188 (“ N , N -Dimethyltryptamine or DMT”) at Canadian manufacturer Dalton Pharma Services.

article thumbnail

New Study: Demographic and policy-based differences in behaviors and attitudes towards driving after marijuana use: an analysis of the 2013–2017 Traffic Safety Culture Index

Cannabis Law Report

We analyzed annual administrations of TSCI from 2013–2017, which asked respondents about various dimensions of traffic safety, including driving after marijuana use [ 28 ]. Between 2013 and 2017, approximately 3000 TSCI surveys were completed annually. 9-tetrahydrocannabinol on driving performance: a randomized clinical trial.

Policy 45
article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Over 1,500 people from around the world attended MAPS’ Psychedelic Science 2013 conference in Oakland, CA. Rick Doblin, Ph.D.,

article thumbnail

Swiss Plan To Let 5,000 Citizens Use Cannabis In Major Medical Trial

Cannabis Law Report

Switzerland’s government will allow 5,000 citizens to use cannabis legally, as part of a country-wide clinical trial. Those who sign up to the trial would receive a small amount of cannabis each month, to smoke or eat. In 2013, Switzerland decriminalized possession of small amounts of cannabis, 10 grammes or less.

article thumbnail

Canada: First patient in Quebec gets approval for magic mushroom therapy

Cannabis Law Report

5 restored its “Special Access Program” — abolished under former prime minister Stephen Harper in 2013 — allowing health-care experts to request access to restricted drugs that have not yet been authorized for sale in the country. .” Health Canada on Jan.

Therapy 52